Current concepts about the pathogenesis of silicosis and asbestosis.
Silicosis and asbestosis are two forms of fibrotic lung disease resulting from the inhalation of inert materials indigestible by pulmonary alveolar macrophages. Results of studies of the host response to these particulates have not always been consistent. It is clear, however, that after phagocytosis, both cause alveolar macrophage damage, with resultant release of macrophage products, including fibrogenic factors and chemotactic factors for neutrophils. The latter cells also release lysosomal enzymes and free radicals when exposed to silica and asbestos. The net effect of these observations suggests that the combination of tissue damage and fibroblast stimulation results in the pulmonary fibrosis characterizing these diseases. Patients with silicosis and asbestosis have normal or decreased cell-mediated and increased humoral immunity with a high incidence of circulating immune complexes and autoantibodies. Whether these abnormalities are related to the pathogenesis of pulmonary fibrosis or are epiphenomena remains to be determined.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001194:Asbestos / Q000494:pharmacology; D001195:Asbestosis / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D012822:Silicon Dioxide / Q000494:pharmacology; D012829:Silicosis / Q000276:immunology*
D001194:Asbestos; D012822:Silicon Dioxide